International Nonproprietary Names for Pharmaceutical
GUIDANCE ON THE USE OF INTERNATIONAL
Suggested citation. Guidance on the use of international nonproprietary names (INNs) for pharmaceutical substances. Geneva: World Health Organization; 2017. |
International Nonproprietary Names for Pharmaceutical Substances
Names for Pharmaceutical. Substances (INN). RECOMMENDED International Nonproprietary Names: List 85. Notice is hereby given that in accordance with |
International Nonproprietary Names for Pharmaceutical Substances
31 ??? 2011 International Nonproprietary Names for. Pharmaceutical Substances (INN). Notice is hereby given that in accordance with article 3 of the ... |
International Nonproprietary Names for Pharmaceutical Substances
28 ??? 2022 International Nonproprietary. Names for Pharmaceutical. Substances (INN). Notice is hereby given that in accordance with article 3 of the ... |
International Nonproprietary Names for Pharmaceutical Substances
International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org. 1955 |
International Nonproprietary Names for Pharmaceutical Substances
R4 (EB115/2005/REC/1)] the following names are selected as Recommended International Nonproprietary Names. The inclusion of a name in the lists of Recommended. |
International Nonproprietary Names for Pharmaceutical Substances
7 ???? 2017 Recommended International Nonproprietary Names for Pharmaceutical Substances the names given in the list on the following pages are under ... |
WORLD HEALTH ORGANIZATION International Nonproprietary
9 ??? 2004 procedure for the selection of International Nonproprietary Names (INN) for pharmaceutical substances.1 The action plan envisaged further ... |
International Nonproprietary Names for Pharmaceutical Substances
International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org. 1955 |
The use of stems in the selection of International Nonproprietary
28 ??? 2013 International Nonproprietary Names for Pharmaceutical Substances" (see Annex 2). 5. Symbol (d) indicates stems that were formerly used ... |
International Nonproprietary Names for Pharmaceutical
Recommended International Nonproprietary Names for Pharmaceutical Substances the names given in the list on the following pages are under consideration by the World Health Organization as Proposed International Nonproprietary Names The inclusion of a name in the lists of Proposed International |
WORLD HEALTH ORGANIZATION International Nonproprietary Names
International Nonproprietary Names for pharmaceutical substances is attached as Annex 1 (with changes to the current procedure printed in bold-face type) including a new proposed working process for the INN Expert Group Amended General principles for guidance in devising International |
Searches related to international nonproprietary names for pharmaceutical PDF
Proposed International Nonproprietary Names: List 115 Comments on or formal objections to the proposed names may be forwarded by any person to the INN Programme of the World Health Organization within four months of the date of their publication in WHO Drug Information i e for List 115 Proposed INN not later than 29 October 2016 |
How many proposed international nonproprietary names are there?
Health Organization as Proposed International Nonproprietary Names. The inclusion of a name in the lists of Proposed International Nonproprietary Names does not imply any recommendation of the use of the substance in medicine or pharmacy. Lists of Proposed (1–117) and Recommended (1–78) International Nonproprietary Names
What is an International Nonproprietary Name (INN)?
International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.
What is a nonproprietary name?
Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. WHO has a constitutional mandate to "develop, establish and promote international standards with respect to biological, pharmaceutical and similar products".
Are nonproprietary names included in the cumulative list of inns?
Nonproprietary Names. WHO is not in a position either to uphold these statements or to comment on the efficacy of the action claimed. Because of their provisional nature, these descriptors will neither be revised nor included in the Cumulative Lists of INNs.
International Nonproprietary Names for Pharmaceutical Substances
The inclusion of a name in the lists of Proposed International Nonproprietary Names does not imply any recommendation of the use of the substance in medicine |
International Nonproprietary Names for Pharmaceutical Substances
R4 (EB115/2005/REC/1)], the following names are selected as Recommended International Nonproprietary Names The inclusion of a name in the lists of |
International Nonproprietary Names for Pharmaceutical - Prescrire
1 jan 2008 · 21, No 4, 2007 Proposed INN: List 98 317 International Nonproprietary Names for Pharmaceutical Substances (INN) Notice is hereby given |
International Nonproprietary Names for
Sometimes herbal drugs are dangerously adulterated or en- riched by the addition of potent synthetic pharma- ceuticals such as anabolic steroids, sedatives and |
Annex 5 International Nonproprietary Names for biological and
Name (INN) Expert Group/WHO Expert Committee on Specifications for Pharmaceutical Preparations, to assign nonproprietary names to medicinal substances |
The use of stems in the selection of International Nonproprietary
Programme on International Nonproprietary Names (INN) Quality Assurance and Safety: Medicines Essential Medicines and Pharmaceutical Policies |
International Nonproprietary Names for Pharmaceutical - WIPO
7 oct 1999 · Third Session Geneva, November 8 to 12, 1999 INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES |
The School of International Nonproprietary Names - World Health
The main objective of the programme is to define a single, unique, globally accepted name for each pharmaceutical substance The INN Programme is now |